Multiple ligands of von willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma

Journal of Biological Chemistry

Volumn 288, Issue 39, 2013, Pages 28283-28292

  Thomer, Lena ^a   Schneewind, Olaf ^a   Missiakas, Dominique ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEINS; BLOOD COAGULATION; CLOT FORMATION; HUMAN PLASMAS; MACROMOLECULAR COMPLEXES; MULTIPLE LIGANDS; STAPHYLOCOCCUS AUREUS; VON WILLEBRAND FACTOR;

BACTERIA; PLASMA (HUMAN); PROTEINS;

GLYCOPROTEINS;

BINDING PROTEIN; BLOOD CLOTTING FACTOR 13; COAGULASE; FIBRIN; FIBRINOGEN; FIBRONECTIN; LIGAND; PROTHROMBIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VON WILLEBRAND FACTOR BINDING PROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME PURIFICATION; ESCHERICHIA COLI; HEMOSTASIS; HUMAN; IMMUNOBLOTTING; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; STAPHYLOCOCCUS AUREUS;

COAGULASE; COAGULATION FACTORS; FACTOR XIII; FIBRIN; FIBRINOGEN; FIBRONECTIN; STAPHYLOCOCCUS AUREUS; VWBP;

BACTERIAL PROTEINS; BLOOD COAGULATION; COAGULASE; FACTOR XIII; FIBRINOGEN; FIBRONECTINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LIGANDS; MACROMOLECULAR SUBSTANCES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTHROMBIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS; VON WILLEBRAND FACTOR;

EID: 84884788509     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.493122     Document Type: Article

References (51)

1. Lowy, F. D. (1998) Staphylococcus aureus infections. New Engl. J. Med. 339, 520-532
2. Klevens, R. M., Morrison, M. A., Nadle, J., Petit, S., Gershman, K., Ray, S., Harrison, L. H., Lynfield, R., Dumyati, G., Townes, J. M., Craig, A. S., Zell, E. R., Fosheim, G. E., McDougal, L. K., Carey, R. B., and Fridkin, S. K. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298, 1763-1771
3. Bamberger, D. M., and Boyd, S. E. (2005) Management of Staphylococcus aureus infections. Am. Fam. Physician 72, 2474-2481
4. Weems, J. J., Jr. (2001) The many faces of Staphylococcus aureus infection. Recognizing and managing its life-threatening manifestations. Postgrad. Med. 110, 24-26
5. Grundmann, H., Aires-de-Sousa, M., Boyce, J., and Tiemersma, E. (2006) Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368, 874-885
6. Adams, R. L., and Bird, R. J. (2009) Coagulation cascade and therapeutics update. Relevance to nephrology. Overview of coagulation, thrombophilias, and history of anticoagulants. Nephrology 14, 462-470
7. Levi, M., Keller, T. T., van Gorp, E., and ten Cate, H. (2003) Infection and inflammation and the coagulation system. Cardiovasc. Res. 60, 26-39
8. Frick, I. M., Björck, L., and Herwald, H. (2007) The dual role of the contact system in bacterial infectious disease. Thromb. Haemost. 98, 497-502
9. Herwald, H., Mörgelin, M., Dahlbäck, B., and Björck, L. (2003) Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma, J. Thromb. Haemost. 1, 284-291
10. Loof, T. G., Morgelin, M., Johansson, L., Oehmcke, S., Olin, A. I., Dickneite, G., Norrby-Teglund, A., Theopold, U., and Herwald, H. (2011) Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood 11, 2589-2598
11. Levi, M., van der Poll, T., ten Cate, H., and van Deventer, S. J. (1997) The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur. J. Clin. Invest. 27, 3-9
12. Loeb, L. (1903) The influence of certain bacteria on the coagulation of blood. J. Med. Res. 10, 407-419
13. Bjerketorp, J., Nilsson, M., Ljungh, A., Flock, J. I., Jacobsson, K., and Frykberg, L. (2002) A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. Microbiology 148, 2037-2044
14. Friedrich, R., Panizzi, P., Fuentes-Prior, P., Richter, K., Verhamme, I., Anderson, P. J., Kawabata, S., Huber, R., Bode, W., and Bock, P. E. (2003) Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 425, 535-539
15. Kroh, H. K., Panizzi, P., and Bock, P. E. (2009) von Willebrand factorbinding protein is a hysteretic conformational activator of prothrombin. Proc. Natl. Acad. Sci. U.S.A. 106, 7786-7791
16. Hendrix, H., Lindhout, T., Mertens, K., Engels, W., and Hemker, H. C. (1983) Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J. Biol. Chem. 258, 3637-3644
17. Panizzi, P., Nahrendorf, M., Figueiredo, J. L., Panizzi, J., Marinelli, B., Iwamoto, Y., Keliher, E., Maddur, A. A., Waterman, P., Kroh, H. K., Leuschner, F., Aikawa, E., Swirski, F. K., Pittet, M. J., Hackeng, T. M., Fuentes-Prior, P., Schneewind, O., Bock, P. E., and Weissleder, R. (2011) In vivo detection of Staphylococcus aureus endocarditis by targeting pathogenspecific prothrombin activation. Nat. Med. 17, 1142-1146
18. Cheng, A. G., McAdow, M., Kim, H. K., Bae, T., Missiakas, D. M., and Schneewind, O. (2010) Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog. 6, e1001036
19. McAdow, M., Kim, H. K., Dedent, A. C., Hendrickx, A. P., Schneewind, O., and Missiakas, D. M. (2011) Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog. 7, e1002307
20. McAdow, M., DeDent, A. C., Emolo, C., Cheng, A. G., Kreiswirth, B. N., Missiakas, D. M., and Schneewind, O. (2012) Coagulases as determinants of protective immune responses against Staphylococcus aureus. Infect. Immun. 80, 3389-3398
21. Panizzi, P., Friedrich, R., Fuentes-Prior, P., Bode, W., and Bock, P. E. (2004) The staphylocoagulase family of zymogen activator and adhesion proteins. Cell. Mol. Life Sci. 61, 2793-2798
22. Palma, M., Shannon, O., Quezada, H. C., Berg, A., and Flock, J. I. (2001) Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the β-chain. J. Biol. Chem. 276, 31691-31697
23. Baba, T., Bae, T., Schneewind, O., Takeuchi, F., and Hiramatsu, K. (2008) Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes, J. Bacteriol. 190, 300-310
24. Hanahan, D. (1983) Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166, 557-580
25. Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990) Use of T7 polymerase to direct expression of cloned genes. Methods Enzymol. 185, 60-89
26. Anderson, N. L., and Anderson, N. G. (2002) The human plasma proteome. History, character, and diagnostic prospects. Mol. Cell Proteomics 1, 845-867
27. Mosher, D. F., and Furcht, L. T. (1981) Fibronectin. Review of its structure and possible functions. J. Invest. Dermatol. 77, 175-180
28. Schwartz, M. L., Pizzo, S. V., Hill, R. L., and McKee, P. A. (1973) Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J. Biol. Chem. 248, 1395-1407
29. Ariëns, R. A., Lai, T. S., Weisel, J. W., Greenberg, C. S., and Grant, P. J. (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100, 743-754
30. Skrzynia, C., Reisner, H. M., and McDonagh, J. (1982) Characterization of the catalytic subunit of factor XIII by radioimmunoassay. Blood 60, 1089-1095
31. Nagy, J. A., Kradin, R. L., and McDonagh, J. (1988) Biosynthesis of factor XIII A and B subunits. Adv. Exp. Med. Biol. 231, 29-49
32. Siebenlist, K. R., and Mosesson, M. W. (1994) Progressive cross-linking of fibrin chains increases resistance to fibrinolysis, J. Biol. Chem. 269, 28414-28419
33. Greinacher, A., and Warkentin, T. E. (2008) The direct thrombin inhibitor hirudin. Thromb. Haemost. 99, 819-829
34. Curtis, C. G., Brown, K. L., Credo, R. B., Domanik, R. A., Gray, A., Stenberg, P., and Lorand, L. (1974) Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Biochemistry 13, 3774-3780
35. Parry, M. A., Fernandez-Catalan, C., Bergner, A., Huber, R., Hopfner, K. P., Schlott, B., Gührs, K. H., and Bode, W. (1998) The ternary microplasminstaphylokinase-microplasmin complex is a proteinase-cofactor- substrate complex in action. Nat. Struct. Biol. 5, 917-923
36. Loof, T. G., Schmidt, O., Herwald, H., and Theopold, U. (2011) Coagulation systems of invertebrates and vertebrates and their roles in innate immunity. The same side of two coins? J. Innate Immun. 3, 34-40
37. Cheng, A. G., DeDent, A. C., Schneewind, O., and Missiakas, D. (2011) A play in four acts. Staphylococcus aureus abscess formation. Trends Microbiol. 19, 225-232
38. Cheng, A. G., Kim, H. K., Burts, M. L., Krausz, T., Schneewind, O., and Missiakas, D. M. (2009) Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J. 23, 3393-3404
39. Guggenberger, C., Wolz, C., Morrissey, J. A., and Heesemann, J. (2012) Two distinct coagulase-dependent barriers protect Staphylococcus aureus from neutrophils in a three dimensional in vitro infection model. PLoS Pathog. 8, e1002434
40. Kroh, H. K., and Bock, P. E. (2012) Effect of zymogen domains and active site occupation on activation of prothrombin by von Willebrand Factorbinding protein. J. Biol. Chem. 287, 39149-39157
41. Greenberg, C. S., Miraglia, C. C., Rickles, F. R., and Shuman, M. A. (1985) Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. J. Clin. Invest. 75, 1463-1470
42. Siebenlist, K. R., Meh, D. A., and Mosesson, M. W. (1996) Plasma factor XIII binds specifically to fibrinogen molecules containing chains. Biochemistry 35, 10448-10453
43. Fornace, A. J., Jr., Cummings, D. E., Comeau, C. M., Kant, J. A., and Crabtree, G. R. (1984) Structure of the human β-fibrinogen gene. Alternate mRNA splicing near the 3 end of the gene produces A and B forms of β-fibrinogen. J. Biol. Chem. 259, 12826-12830
44. Wolfenstein-Todel, C., and Mosesson, M. W. (1981) Carboxyl-terminal amino acid sequence of a human fibrinogenβ-chain variant (). Biochemistry 20, 6146-6149
45. Muszbek, L., Yee, V. C., and Hevessy, Z. (1999) Blood coagulation factor XIII. Structure and function. Thromb. Res. 94, 271-305
46. Credo, R. B., Curtis, C. G., and Lorand, L. (1978) Ca2β-related regulatory function of fibrinogen. Proc. Natl. Acad. Sci. U.S.A. 75, 4234-4237
47. Blombäck, B., Procyk, R., Adamson, L., and Hessel, B. (1985) FXIII induced gelation of human fibrinogen. An alternative thiol-enhanced, thrombinindependent pathway. Thromb. Res. 37, 613-627
48. Siebenlist, K. R., Meh, D. A., and Mosesson, M. W. (2001) Protransglutaminase (factor XIII) mediated cross-linking of fibrinogen and fibrin. Thromb. Haemost. 86, 1221-1228
49. Okada, M., Blombäck, B., Chang, M. D., and Horowitz, B. (1985) Fibronectin and fibrin gel structure. J. Biol. Chem. 260, 1811-1820
50. Chow, T. W., McIntire, L. V., and Peterson, D. M. (1983) Importance of plasma fibronectin in determining PFP and PRP clot mechanical properties. Thromb. Res. 29, 243-248
51. Matsuka, Y. V., Anderson, E. T., Milner-Fish, T., Ooi, P., and Baker, S. (2003) Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa. Evidence for factor XIIIa-catalyzed covalent crosslinking to fibronectin and fibrin. Biochemistry 42, 14643-14652